ORCID Profile
0000-0003-3060-3323
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Publisher: Georg Thieme Verlag KG
Date: 2017
Abstract: Objective The objective of this study was to compare clinical outcomes of preecl tic pregnancies according to the proteinuria level. Study Design Secondary analysis of a multicenter prospective cohort study of women with preecl sia (PE) symptomatology. Nonproteinuria, mild-proteinuria, and massive-proteinuria PEs were defined as: 165 mg in 12 hours or 300 mg in 24 hours, 165 mg to 2.69 g in 12 hours or 300 mg to 4.99 g in 24 hours, and ≥ 2.7 g in 12 hours or ≥ 5.0 g in 24 hours, respectively. In idual and composite maternal, fetal, and neonatal outcomes were compared among the PE groups. Results Of the 406 analyzed pregnancies, 36 (8.8%) had massive-proteinuria PE, 268 (66.0%) mild-proteinuria PE, and 102 (25.1%) nonproteinuria PE. Compared with the other groups, massive-proteinuria PE women had significantly higher blood pressures (p 0.001), epigastric pain (p = 0.007), and uric acid serum levels (p 0.001) prior to delivery. Composite maternal morbidity was similar across the groups. Delivery 340/7 weeks occurred in 80.6, 49.3, and 22.5% of massive-proteinuria, mild-proteinuria, and nonproteinuria PE groups, respectively (p 0.0001). Composite adverse neonatal outcomes were significantly higher in the massive-proteinuria PE compared with the other groups (p = 0.001). Conclusion While potentially not important diagnostically, massive proteinuria is associated with more severe clinical manifestations of PE prompting earlier delivery.
Location: United States of America
Location: United States of America
Location: United States of America
No related grants have been discovered for Qing Li.